Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Hyperthyroidism × Clear all

Status

Sponsor Class

OTHER 15 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 451 Neoplasms 343 Lymphoma 304 Prostatic Neoplasms 260 Melanoma 258 Carcinoma, Non-Small-Cell Lung 250 Lung Neoplasms 231 Precursor Cell Lymphoblastic Leukemia-Lymphoma 229 Leukemia 218 Leukemia, Lymphocytic, Chronic, B-Cell 216 Leukemia, Myeloid, Acute 210 Colonic Neoplasms 206 Lymphoma, Non-Hodgkin 204 Brain Neoplasms 188 Lymphoma, Large B-Cell, Diffuse 187 Ovarian Neoplasms 186 Colorectal Neoplasms 185 Rectal Neoplasms 180 Lymphoma, Follicular 177 Multiple Myeloma 171 Neoplasm Metastasis 166 Burkitt Lymphoma 162 Carcinoma, Renal Cell 156 Sarcoma 154 Glioblastoma 147 Lymphoma, Mantle-Cell 146 Pancreatic Neoplasms 143 Unspecified Adult Solid Tumor, Protocol Specific 132 Central Nervous System Neoplasms 128 Lymphoma, B-Cell, Marginal Zone 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02989103 2020-10-29

Hyperthyroid Follow-Up Study

National Institutes of Health Clinical Center (CC)

35,593 enrolled

Hyperthyroidism, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡